Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Current Assets: 2009-2012

Historic Current Assets for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $216.1 million.

  • Lexicon Pharmaceuticals' Current Assets rose 45.04% to $216.1 million in Q3 2012 from the same period last year, while for Sep 2012 it was $216.1 million, marking a year-over-year increase of 45.04%. This contributed to the annual value of $285.8 million for FY2011, which is 33.09% up from last year.
  • Lexicon Pharmaceuticals' Current Assets amounted to $216.1 million in Q3 2012, which was down 9.31% from $238.3 million recorded in Q2 2012.
  • Lexicon Pharmaceuticals' Current Assets' 5-year high stood at $321.9 million during Q1 2010, with a 5-year trough of $94.2 million in Q1 2009.
  • For the 3-year period, Lexicon Pharmaceuticals' Current Assets averaged around $233.2 million, with its median value being $235.6 million (2010).
  • In the last 5 years, Lexicon Pharmaceuticals' Current Assets spiked by 241.67% in 2010 and then tumbled by 40.10% in 2011.
  • Lexicon Pharmaceuticals' Current Assets (Quarterly) stood at $169.7 million in 2009, then rose by 26.55% to $214.7 million in 2010, then surged by 33.09% to $285.8 million in 2011, then spiked by 45.04% to $216.1 million in 2012.
  • Its Current Assets stands at $216.1 million for Q3 2012, versus $238.3 million for Q2 2012 and $259.0 million for Q1 2012.